Dr. Amgad Droby
My research focuses mainly on the investigation of novel early biomarkers for neurodegenerative diseases, as well as studying the interplay between neurodegenerative and compensatory processes in these individuals applying in vivo multimodal imaging approaches using structural and functional magnetic resonance imaging (MRI).
Brain Disorders Research
Clinical Neuroscience
Imaging Research
1. Droby A, Yoffe-Vasiliev A, Atias D, Fraser KB, Mabrouk OS, Omer N, Bar Shira A, Gana Weisz M, Goldstein O, Artzi M, Ben Bashat D, Alacaly RN, Orr-Urtreger A, Shirvan JC, Cedarbaum JM, Giladi N, Mirelman A, Thaler A. Radilogical merkers of CSF a-synuclein aggregation in Parkinson’s disease patients. NPJ Parkinsons Dis. 2025; 11:7.
2. Omer N, Droby A, Silbak R, Trablus N, Bar David A, Shiner T, Alcaly Y, Alcalay RN, Nathan T, Thaler A, Mirelman A, Gana Weisz M, Goldstein O, Galinka T, Orr-Urtreger A, Giladi N, Bregman N. White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakov disease (gCJD). J Neurol Neurosurg Psychiatry. 2005; 96:3):226-230
3. Droby A, Thaler A, Mirelman A. Imaging markers in genetic forms of Parkinson’s disease. Brain Sci. 2023. Doi:10.33390/brainsci13081212
4. Droby A, Artzi M, Lerman H, Hutchison RM, Ben Bashat D, Omer N, Gurevich T, Orr-Urtreger A, Cohen B, Cedarbaum JM, Even Sapir E, Giladi N, Mirelman A, Thaler A. Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers. NPJ Parkinson's Dis 2022; 8(1):20.
5. Droby A, Varangis E, Habeck C, Hausdorff JM, Stern Y, Mirelman A, Maidan I. Effects of aging on cognitive and brain inter-network integration patterns underlying usual and dual-task gait performance. Frontiers in Aging Neuroscience. 2022 Sep 28:14:956744.
